Sun Pharma’s $11.75 billion Organon bet marks India Inc’s biggest pharma buy
Sun Pharma will acquire US-based Organon in a $12 billion deal, inheriting $8.6 billion debt and strengthening its specialty, biosimilars and women’s health presence in the US market.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
